Parliamentary inspection to convene from October 11

The parliamentary audit, which will begin from October 11-30, is expected to deal with many issues, including a fabricated bioequivalence data, during its 20-day session.

Earlier, the Korea Food and Drug Administration (KFDA) unveiled mid-term results of its ongoing investigation into 35 pharmaceutical testing sites, including bio-venture companies and academic institutions, to check if they...